Jeffrey Vinik
Angel Investor
Deal, United States
Jeffrey Vinik is a seed investor in Deal focused on Software and Health Care. Jeffrey N. Vinik is the current owner of the Tampa Bay Lightning and the Tampa Bay Storm, as well as a minority owner of the Boston Red Sox. He is also on the board of directors for Liverpool Football Club of the Premier League.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Jeffrey Vinik invests in
Stages Jeffrey Vinik invests in
Countries Jeffrey Vinik invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 5 (25%)
- Health Care 5 (25%)
- Information Technology 3 (15%)
- SaaS 2 (10%)
- Gaming 2 (10%)
Stage
- Seed 4 (20%)
- Series C 4 (20%)
- Series A 3 (15%)
- Series B 3 (15%)
- Funding Round 3 (15%)
Country
- United States 14 (70%)
- Israel 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Homee
|
Homee is a technology platform for connecting insurers, policyholders, and service providers in the claims process. They facilitate scheduled and emergency mitigations and repairs. They create tools for insurance to connect policyholders and service providers in the claims process. Their network of registered restoration contractors, plumbers, andelectricians specializes in claim and repair services. | $12M / Series C / Oct 29, 2024 | |
Evolved By Nature
|
Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its firstapplication in 2014. | $120M / Series C / Jun 30, 2022 | |
|
Evolved By Nature
|
Evolved by Nature, based in Boston, was started by biomedical engineer Rebecca Lacouture and chemist Gregory Altman in 2013. Their product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company has patented dozens of molecular combinations of the natural silk protein since filing its firstapplication in 2014. | $70M / Series B / Dec 24, 2021 | |
4D Sight
|
Deep video monetization platform. | Nov 03, 2021 | |
|
4D Sight
|
Deep video monetization platform. | Pre-Seed / Nov 03, 2021 | |
TripFusion by Vacayou Wellness Travel
|
Vacayou Wellness & Active Travel connects customers with life enriching wellness retreats & active travel experiences across the globe. Your experts to research and book wellness travel. | $1.6M / Seed / May 18, 2021 | |
|
TripFusion by Vacayou Wellness Travel
|
Vacayou Wellness & Active Travel connects customers with life enriching wellness retreats & active travel experiences across the globe. Your experts to research and book wellness travel. | $1.6M / Convertible Note / May 18, 2021 | |
Bridge Connector
|
Bridge Connector delivers an end-to-end suite of solutions to transform the way health care communicates. Its core integration-platform-as-a-service (iPaaS) offering empowers health care provider organizations across the continuum of care with the ability to easily integrate traditionally disparate, mission-critical platforms such as electronichealth records (EHRs) and customer relationship management systems (CRMs) without the use of code. Bridge Connector’s integration technologies help health care organizations unlock high-impact clinical and operational insights and automate workflows without the need for deep technical expertise. Bridge Connector is headquartered in Nashville, Tennessee, and also has offices in San Francisco and Palm Beach Gardens, Florida. | $25.5M / Series B / Aug 18, 2020 | |
|
Bridge Connector
|
Bridge Connector delivers an end-to-end suite of solutions to transform the way health care communicates. Its core integration-platform-as-a-service (iPaaS) offering empowers health care provider organizations across the continuum of care with the ability to easily integrate traditionally disparate, mission-critical platforms such as electronichealth records (EHRs) and customer relationship management systems (CRMs) without the use of code. Bridge Connector’s integration technologies help health care organizations unlock high-impact clinical and operational insights and automate workflows without the need for deep technical expertise. Bridge Connector is headquartered in Nashville, Tennessee, and also has offices in San Francisco and Palm Beach Gardens, Florida. | Convertible Note / Dec 11, 2019 | |
Satisfi Labs
|
Satisfi Labs provide digital workforces in industries, AI assistants are an essential staffing solution to help brands meet their growing customer needs. | $3M / Mar 28, 2019 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jeffrey Vinik invest in?
Jeffrey Vinik invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Series C stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jeffrey Vinik?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jeffrey Vinik last invest?
The most recent investment recorded for Jeffrey Vinik closed in Oct 2024. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
